Scott Andrew Smith

Scott Andrew Smith, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in BioAtla, Inc. and Viatris Inc. Over a trading history stretching from 14 June 2021 to 6 March 2026, the count stands at 47 filings.

In open-market terms, that means 2 purchases worth €671k on one side and 5 sales worth €754k on the other. Sales outweigh purchases by €83k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 35 share grants and 4 option exercises.

The record was last updated on 10 March 2026 with an option exercise in Viatris Inc. The last purchase on record was published on 13 August 2025, which is 431 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.